CytRx Co. (OTCMKTS:CYTR – Get Rating) was the target of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 20,900 shares, a decline of 60.3% from the April 30th total of 52,700 shares. Based on an average daily trading volume, of 302,100 shares, the […]
Novavax (NASDAQ:NVAX – Get Rating) and CytRx (NASDAQ:CYTR – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation. Valuation & Earnings This table compares Novavax and CytRx’s top-line revenue, earnings […]
CytRx (NASDAQ:CYTR – Get Rating) and Gritstone bio (NASDAQ:GRTS – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability. Profitability This table compares CytRx and Gritstone bio’s net margins, […]